Catalyst Pharmaceuticals, Inc. logo

Catalyst Pharmaceuticals, Inc.

NASDAQ:CPRX

Overview | Financials
Company Name Catalyst Pharmaceuticals, Inc.
Symbol CPRX
Currency USD
Price 15.45
Market Cap 1,824,876,750
Dividend Yield 0%
52-week-range 11.49 - 17.5
Industry Biotechnology
Sector Healthcare
CEO Mr. Patrick J. McEnany
Website https://www.catalystpharma.com

An error occurred while fetching data.

About Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of

Related Stocks

IGM Biosciences, Inc. logo

IGM Biosciences, Inc.

IGMS

8.08 USD

Deciphera Pharmaceuticals, Inc. logo

Deciphera Pharmaceuticals, Inc.

DCPH

25.59 USD

TG Therapeutics, Inc. logo

TG Therapeutics, Inc.

TGTX

16.81 USD

DocGo Inc. logo

DocGo Inc.

DCGO

3.15 USD

Theravance Biopharma, Inc. logo

Theravance Biopharma, Inc.

TBPH

8.64 USD

Editas Medicine, Inc. logo

Editas Medicine, Inc.

EDIT

6.04 USD

Pulmonx Corporation logo

Pulmonx Corporation

LUNG

6.79 USD

Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp.

AVXL

3.75 USD

Financials

Numbers are in millions USD

Numbers are in millions USD